Skip to Content
  • Correction
  • Open Access

28 April 2023

1 Page

Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794

,
,
,
,
,
,
,
,
and
1
Department of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany
2
Department of Transplantation Immunology, University of Heidelberg, 69120 Heidelberg, Germany
3
Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
This article belongs to the Section Immunology & Rheumatology

Text Correction

There was an error in the original publication [1]. In all parts of the manuscript, the used cell line for the analyses was defined as “HepG2” instead of “HepaRG”. The corrections have been made to all sections of the manuscript by replacing “HepG2” with “HepaRG”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Oweira, H.; Lahdou, I.; Mehrle, S.; Khajeh, E.; Nikbakhsh, R.; Ghamarnejad, O.; Terness, P.; Reißfelder, C.; Sadeghi, M.; Ramouz, A. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.